To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
HR 7347 requires the Secretary of Veterans Affairs to report to Congress within 180 days after a psychedelic drug receives FDA approval or licensing under federal law. The report must state whether the drug will be added to the VA’s formulary (approved treatment list) and provide the Secretary’s justification for that decision. This bill does not change VA policy but mandates transparency about future decisions regarding psychedelic drugs for veterans.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2024
Committee Review
Floor Vote
President
Introduced Feb 14, 2024
Last action Sep 6, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
10
Key actions
5
Committee
7
Sep 6, 2024
Lower · Passed
Reported by the Committee on Veterans' Affairs. H. Rept. 118-647.
lower
May 1, 2024
Lower · Passed
Committee Consideration and Mark-up Session Held
lower
Apr 16, 2024
Lower · Passed
Forwarded by Subcommittee to Full Committee by Voice Vote.
lower
Apr 16, 2024
Lower · Passed
Subcommittee Consideration and Mark-up Session Held
lower
Mar 21, 2024
Lower · Passed
Subcommittee Hearings Held
lower
Feb 29, 2024
Committee
Referred to the Subcommittee on Health.
lower
Feb 14, 2024
Committee
Referred to the House Committee on Veterans' Affairs.
lower
Feb 14, 2024
Introduced
Introduced in House
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 7347
Scope: US
Hi! I can help you understand HR 7347. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline